VRCA Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.

$10.46  -0.65 (-5.85%)
As of 11/26/2021 13:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/15/2018
Outstanding shares:  27,519,053
Average volume:  41,141
Market cap:   $305,736,679
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92511W108
ISIN:        US92511W1080
Sedol:      BZ1NTH2
Valuation   (See tab for details)
PE ratio:   -307.54
PB ratio:   7.05
PS ratio:   25.48
Return on equity:   -94.28%
Net income %:   -320.98%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy